FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
about
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancersPersonalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsA secretory cell type develops alongside multiciliated cells, ionocytes and goblet cells, and provides a protective, anti-infective function in the frog embryonic mucociliary epidermisFOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotypeIntegrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma.Forkhead box J1 expression is upregulated and correlated with prognosis in patients with clear cell renal cell carcinoma.Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.FOXA1: master of steroid receptor function in cancer.MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.Clinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.The clinical significance of forkhead box protein A1 and its role in colorectal cancer.FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasisFOXA1: a transcription factor with parallel functions in development and cancer.Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer.Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer.Forkhead box A1 (FOXA1) tagging polymorphisms and esophageal cancer risk in a Chinese population: a fine-mapping study.FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.FOXA1 mutations in hormone-dependent cancers.MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.FOXA1 transcriptionally up-regulates cyclin B1 expression to enhance chondrosarcoma progression
P2860
Q24630926-89FAB3CB-EF49-4870-8DED-49DD26186090Q27027491-96A37D5D-C873-4FDC-B6EC-24A121187FD0Q28657650-E1BB1DC2-E342-41D0-97C2-5EFD562AEA46Q31083556-C5789AA5-C6D9-43E4-BB19-55E0239D1294Q33733903-54356CFD-556B-4781-9C68-0C6C2173B0E7Q34150131-5A67AC2E-1FB2-4F50-8AC2-2D556A116FC4Q34503610-ED3E3E1E-A838-48D0-8EC4-89C96C34676BQ34776121-233B91CD-D6F6-4FC6-8951-00CE43BB75A9Q35089958-CCAD515A-ED86-46D7-AA12-2CD1B98B2577Q35160562-26F09786-7F30-4502-B972-4BFB0F2BC865Q35532767-1F300E35-25A1-47A9-B6F4-313398E4AD1FQ35955257-6A0C9A45-B235-401B-B4B0-C08059369C3DQ36171837-56115377-FB81-4420-B38E-1459E1ADBD57Q36953276-80C9D66A-DEF5-4133-801E-EE73711CEF83Q37190816-3C9F0570-69D9-4D8A-8A8D-AF7B03D80D89Q37379842-64624172-6C83-428A-9B0D-E5C4E222B6E9Q37706305-B6126BA5-9E46-4FB5-B131-44A3B0543C1AQ37960622-9F4D6449-8DD1-4D7E-9CF4-914FB660FEA4Q38538387-59CA67D8-29CC-49F8-A52D-A4829DC94F7BQ38851509-E02745A0-A041-40F4-8660-60030755F878Q39367201-EF6127E3-6BA7-4E21-A183-36C0429B4C3BQ40363271-FF16E5E3-FB51-44DF-9236-61C42A991D6EQ40815034-55E3FF4E-6922-4651-BC7F-30EDA3716509Q41926547-FC743436-7974-420E-840B-BADC2C767135Q43247422-89590E7E-C9DB-4C3E-BBE1-E816A14D8A8FQ47799652-75DBEB50-C5E0-4446-A983-1AA541F2B195Q48632489-9A772715-F2A7-4BE4-9131-A048277DC4EEQ52655148-1FF923B0-C981-4368-A1BC-5CA3BC919E2BQ58790055-969FFD2B-A33A-4F98-9E95-B85C6841E12F
P2860
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@ast
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@en
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@nl
type
label
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@ast
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@en
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@nl
prefLabel
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@ast
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@en
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@nl
P2093
P50
P1476
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
@en
P2093
Alfredo Pontecorvi
Azra H Ligon
Carmelo Nucera
Carmen Priolo
Guido Fadda
Jason S Carroll
Marco Attard
Mary Toner
Vânia Nose
P304
P356
10.1158/1078-0432.CCR-08-3155
P407
P577
2009-05-26T00:00:00Z